Literature DB >> 24607660

The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis.

L K Too1, Helen J Ball1, Iain S McGregor2, Nicholas H Hunt3.   

Abstract

Interferon-gamma is known to play a complex modulatory role in immune defence during microbial infections. Its actions in pneumococcal meningitis, however, remain ill-defined. Here, a pathological role for IFN-γ was demonstrated using a murine model of pneumococcal meningitis, in that C57BL/6J mice deficient in this pro-inflammatory cytokine (IFN-γ(-/-)) showed less severe acute and long-term neuropathology following intracerebral challenge with Streptococcus pneumoniae. The absence of IFN-γ significantly lengthened the survival of mice that otherwise would have developed fatal clinical signs within two days of CNS infection. Compared to their wild-type counterparts, IFN-γ(-/-) mice showed a diminished inflammatory response (attenuated levels of pro-inflammatory cytokines in the cerebrospinal fluid) and milder brain pathologies (less BBB permeability to protein and brain haemorrhage) during the acute phase of disease. Following a full regime of antibiotic treatment, we found substantial brain injuries in the wild-type mice 10days after infection. IFN-γ(-/-) mice, however, showed decreased neuronal damage in both hippocampus and cortex. In the longer term (≈10weeks p.i.), the wild-type mice that had survived meningitis due to antibiotic treatment had neurobehavioural abnormalities including diurnal hypoactivity, nocturnal hyperactivity and impaired performance in a discrimination reversal task. IFN-γ(-/-) mice, concomitantly tested in the automated IntelliCage platform, had reduced behavioural and cognitive disorders compared to wild-type mice. Both IFN-γ(-/-) and wild-type survivors of pneumococcal meningitis showed impaired working memory in the IntelliCage-based complex patrolling task. These observations indicate an association between IFN-γ-driven acute brain pathology and the long-term neurological sequelae resulting from pneumococcal meningitis.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Central nervous system; Cytokine; IntelliCage; Interferon-gamma; Neurological disease; Neurological sequelae; Neuropathology; Pneumococcal meningitis

Mesh:

Substances:

Year:  2014        PMID: 24607660     DOI: 10.1016/j.bbi.2014.02.020

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  15 in total

1.  Autophagy Promotes Microglia Activation Through Beclin-1-Atg5 Pathway in Intracerebral Hemorrhage.

Authors:  Bangqing Yuan; Hanchao Shen; Li Lin; Tonggang Su; Lina Zhong; Zhao Yang
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

Review 2.  The meninges: new therapeutic targets for multiple sclerosis.

Authors:  Abigail E Russi; Melissa A Brown
Journal:  Transl Res       Date:  2014-09-01       Impact factor: 7.012

Review 3.  Is the concept of central nervous system immune privilege irrelevant in the setting of acute infection?

Authors:  Amanda K Huber; David N Irani
Journal:  Front Oncol       Date:  2015-04-28       Impact factor: 6.244

Review 4.  Knocking on Closed Doors: Host Interferons Dynamically Regulate Blood-Brain Barrier Function during Viral Infections of the Central Nervous System.

Authors:  Brian P Daniels; Robyn S Klein
Journal:  PLoS Pathog       Date:  2015-09-17       Impact factor: 6.823

5.  IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions.

Authors:  Darcy Litteljohn; Eric Nelson; Shawn Hayley
Journal:  Front Cell Neurosci       Date:  2014-11-20       Impact factor: 5.505

6.  The kynurenine pathway is involved in bacterial meningitis.

Authors:  Leonam G Coutinho; Stephan Christen; Caroline L Bellac; Fabrícia Lima Fontes; Fladjule Rejane Soares de Souza; Denis Grandgirard; Stephen L Leib; Lucymara F Agnez-Lima
Journal:  J Neuroinflammation       Date:  2014-10-02       Impact factor: 8.322

Review 7.  Blood‒Brain Barrier Pathology and CNS Outcomes in Streptococcus pneumoniae Meningitis.

Authors:  Belinda Yau; Nicholas H Hunt; Andrew J Mitchell; Lay Khoon Too
Journal:  Int J Mol Sci       Date:  2018-11-11       Impact factor: 5.923

8.  Double deficiency of toll-like receptors 2 and 4 alters long-term neurological sequelae in mice cured of pneumococcal meningitis.

Authors:  Lay Khoon Too; Belinda Yau; Alan G Baxter; Iain S McGregor; Nicholas H Hunt
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 9.  Development of Novel Therapeutics Targeting the Blood-Brain Barrier: From Barrier to Carrier.

Authors:  Jia Li; Meng Zheng; Olga Shimoni; William A Banks; Ashley I Bush; Jennifer R Gamble; Bingyang Shi
Journal:  Adv Sci (Weinh)       Date:  2021-06-03       Impact factor: 16.806

10.  Streptococcus pneumoniae capsule determines disease severity in experimental pneumococcal meningitis.

Authors:  Lucy J Hathaway; Denis Grandgirard; Luca G Valente; Martin G Täuber; Stephen L Leib
Journal:  Open Biol       Date:  2016-03       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.